{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:09:54Z","timestamp":1767676194640},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3_suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,3]]},"DOI":"10.1212\/wnl.48.3_suppl_3.10s","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:27:32Z","timestamp":1336915652000},"source":"Crossref","is-referenced-by-count":50,"title":["Evolution of the measurement of quality of life in migraine"],"prefix":"10.1212","volume":"48","author":[{"given":"Glen D.","family":"Solomon","sequence":"first","affiliation":[{"name":"From the Section of Headache, Department of General Internal Medicine, The Cleveland Clinic Foundation, Cleveland, OH."},{"name":"Address correspondence and reprint requests to Dr. Glen D. Solomon, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A-50, Cleveland, OH 44195-5039."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"3","volume":"42","year":"1996","unstructured":"Jhingran P, Cady RK, Rubino J, et al. Improvements in health related quality of life with sumatriptan treatment for migraine. J Fam Pract 1996;42:36-42.","journal-title":"J Fam Pract"},{"key":"e_1_3_1_3_2","first-page":"2","volume":"29","year":"1995","unstructured":"Kaa KA, Carlson JA, Osterhaus JT. Emergency department resource use by patients with migraine and asthma in a health maintenance organization. Ann Pharmacother 1995;29:251-256.","journal-title":"Ann Pharmacother"},{"key":"e_1_3_1_4_2","first-page":"6","volume":"267","year":"1992","unstructured":"Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. JAMA 1992;267:64-69.","journal-title":"JAMA"},{"key":"e_1_3_1_5_2","unstructured":"Headache Classification of the International Headache Society. Classification and diagnostic criteria for headache disorders cranial neuralgia and facial pain. Cephalalgia 1988;81(suppl 7):1-96."},{"key":"e_1_3_1_6_2","first-page":"2","volume":"33","year":"1993","unstructured":"Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Industries Study. Headache 1993;33:29-35.","journal-title":"Headache"},{"key":"e_1_3_1_7_2","first-page":"2","volume":"36","year":"1996","unstructured":"Smith RC. Impact of migraine on the family. Headache 1996;36:278.","journal-title":"Headache"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100047314"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430010011003"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1993.hed3301003.x"},{"key":"e_1_3_1_11_2","first-page":"1","volume":"34","year":"1994","unstructured":"Solomon GD, Skobieranda FG, Gragg LA. Does quality of life differ among headache diagnoses? Analysis using the Medical Outcomes Study instrument. Headache 1994;34:143-147.","journal-title":"Headache"},{"key":"e_1_3_1_12_2","first-page":"2","volume":"33","year":"1993","unstructured":"Skobieranda FG, Solomon GD, Gragg LA. Quality of life changes in headache patients following six months of outpatient treatment: use of the Medical Outcomes Study instrument [abstract]. Headache 1993;33:283.","journal-title":"Headache"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Osterhaus JT Townsend RJ. The quality of life of migraineurs: a cross sectional profile [abstract]. Cephalalgia 1991;11(suppl 11):103-104.","DOI":"10.1177\/0333102491011S1155"},{"key":"e_1_3_1_14_2","first-page":"2","volume":"33","year":"1993","unstructured":"Miller DW, Osterhaus JT, Hirsh JD, et al. Quality of life assessment among migraineurs treated with sumatriptan: preliminary findings [abstract]. Headache 1993;33:278.","journal-title":"Headache"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430010011003"},{"key":"e_1_3_1_16_2","first-page":"7","volume":"26","year":"1988","unstructured":"Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724-735.","journal-title":"Med Care"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199303001-00002"},{"key":"e_1_3_1_18_2","first-page":"3","volume":"15","year":"1995","unstructured":"Dahlof C, Dimenas E. Migraine patients experience poorer subjective well-being\/quality of life even between attacks. Cephalalgia 1995;15:31-36.","journal-title":"Cephalalgia"},{"key":"e_1_3_1_19_2","first-page":"3","volume":"34","year":"1994","unstructured":"Osterhaus JT, Townsend RJ, Gandek B, et al. Measuring the functional status and well-being of patients with migraine headache. Headache 1994;34:337-343.","journal-title":"Headache"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430010011003"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"33","year":"1993","unstructured":"Osterhaus JT, Miller DW. The burden of migraine [abstract]. Headache 1993;33:279.","journal-title":"Headache"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1993.1301001.x"},{"key":"e_1_3_1_23_2","unstructured":"Dahlof C. Flunarizine versus long-acting propranolol in the prophylactic treatment of migraine: a double blind parellel group study. In: Rose FC ed. New advances in headache research. London: Smith-Gordon 1989:281-289."},{"key":"e_1_3_1_24_2","first-page":"2","volume":"32","year":"1992","unstructured":"Solomon GD, Kunkel RS. Long-term use of flurbiprofen in migraine prophylaxis [abstract]. Headache 1992;32:269-270.","journal-title":"Headache"},{"key":"e_1_3_1_25_2","first-page":"1","volume":"8","year":"1995","unstructured":"Solomon GD, Nielson K, Miller D. The effects of sumatriptan on migraine: health related quality of life. Med Interface 1995;8:134-141.","journal-title":"Med Interface"},{"key":"e_1_3_1_26_2","first-page":"4","volume":"35","year":"1995","unstructured":"Solomon GD, Skobieranda FG, Genzen JR. Quality of life assessment among migraine patients treated with sumatriptan. Headache 1995;35:449-454.","journal-title":"Headache"},{"key":"e_1_3_1_27_2","first-page":"3","volume":"15","year":"1995","unstructured":"Beall D, Cohen J, Miller D, et al. An interim analysis of the use of subcutaneous sumatriptan in a managed care setting: effects on health-related quality of life, impact on health care resource use, and clinical efficacy. Pharmacotherapy 1995;15:385.","journal-title":"Pharmacotherapy"},{"key":"e_1_3_1_28_2","first-page":"3","volume":"15","year":"1995","unstructured":"Adelman J, Sharfman M, Johnson R, et al. Impact of oral sumatriptan on health-related quality of life and productivity in health care professionals with migraine: an interim analysis. Pharmacotherapy 1995;15:387.","journal-title":"Pharmacotherapy"},{"key":"e_1_3_1_29_2","unstructured":"Bullinger M Bruggenjurgen B. Quality of life assessment among migraineurs under current treatment and after three months treatment with sumatriptan. Poster presented at the European Federation of Neurological Societies. Berlin December 1993."},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00647843"},{"key":"e_1_3_1_31_2","first-page":"2","volume":"32","year":"1992","unstructured":"Scopp AL, Peters KS. Patient rating of trigger elimination effectiveness in comprehensive migraine treatment program [abstract]. Headache 1992;32:269.","journal-title":"Headache"},{"key":"e_1_3_1_32_2","first-page":"1","volume":"30","year":"1990","unstructured":"VandenBree MB, Passchier J, Emmen HH. Influence of quality of life and stress coping behaviour on headaches in adolescent male students: an explorative study. Headache 1990;30:165-168.","journal-title":"Headache"},{"key":"e_1_3_1_33_2","unstructured":"Solomon GD Litaker DG Genzen JR. Use of the SF-36 to predict response to sumatriptan in migraine patients. Drug Inf J 1996;30 (in press)."},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1983.hed2301002.x"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.48.3_Suppl_3.10S","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:22:40Z","timestamp":1711538560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.48.3_Suppl_3.10S"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":33,"journal-issue":{"issue":"3_suppl_3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["10.1212\/WNL.48.3_Suppl_3.10S"],"URL":"https:\/\/doi.org\/10.1212\/wnl.48.3_suppl_3.10s","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}